Symposia: Cellular Immunotherapies: Early Phase and Investigational Therapies
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, ALL, Hodgkin lymphoma, Lymphoid Leukemias, Acute Myeloid Malignancies, AML, Biological therapies, Translational Research, Lymphomas, Bispecific Antibody Therapy, Clinical Research, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Diseases, Therapies, Immunotherapy, therapy sequence, Lymphoid Malignancies, Myeloid Malignancies, Natural Killer (NK) Cell Therapies, Transplantation, Vaccines
Type: Oral
Hematology Disease Topics & Pathways:
Research, clinical trials, ALL, Hodgkin lymphoma, Lymphoid Leukemias, Acute Myeloid Malignancies, AML, Biological therapies, Translational Research, Lymphomas, Bispecific Antibody Therapy, Clinical Research, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Diseases, Therapies, Immunotherapy, therapy sequence, Lymphoid Malignancies, Myeloid Malignancies, Natural Killer (NK) Cell Therapies, Transplantation, Vaccines
Monday, December 11, 2023: 10:30 AM-12:00 PM
Room 6CF
(San Diego Convention Center)
Moderators:
Paolo Strati, MD, MD Anderson Cancer Center
and
John C Molina, MD, MEd, Taussig Cancer Institute, Cleveland Clinic Foundation
Disclosures:
Molina: Autolus: Consultancy, Honoraria.
10:30 AM
10:45 AM
11:00 AM
11:15 AM
11:30 AM
11:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH